KIG
HZNP

Kessler Investment Group’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Kessler Investment Group’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-8,516
Closed -$65K – 113
2013
Q4 		$65K Buy
+8,516
New +$45.9K 0.12% 70

Other funds holding HZNP

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
MRM
Michael R. Murphy $255M AUM 0.87% 1-Year Est. Return
BlackRock Fund Advisors
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
TimesSquare Capital Management
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Kessler Investment Group's HZNP Position: Q1 2014 in Review

Kessler Investment Group sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q1 2014, closing a stake of 8,516 shares — an estimated $65K sold.

Kessler Investment Group first reported a position in HZNP in Q4 2013 and held it in 1 quarter. The position peaked at $65K in Q4 2013. 118 funds tracked by Wall St. Rank hold HZNP as of Q1 2014.

  • Kessler Investment Group reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q1 2014 after selling out during the quarter.
  • Kessler Investment Group sold 8,516 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q1 2014, an estimated $65K.
  • Kessler Investment Group first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2013 and held it in 1 quarter.
  • Kessler Investment Group's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $65K in Q4 2013.
  • 118 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q1 2014.

Based on Kessler Investment Group's 13F filing for Q1 2014, filed 10 Apr 2014.